Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 17.05
0.00 (0.00%)
Jul 7, 2026, 12:01 PM CST
Neith Market Cap
Neith has a market cap or net worth of 710.2 million as of July 14, 2026. Its market cap has decreased by -40.18% in one year.
Market Cap
710.20M
Enterprise Value
575.65M
Revenue
32.03M
Ranking
n/a
PE Ratio
1,495.16
Stock Price
17.05
Market Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 710.20M, an increase of 46.81%. That is a compound annual growth rate of 1.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 710.20M | -20.88% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 973.67M |
| TCI GENE | 965.74M |
| Meribank Biotech | 964.56M |
| Taiwan Advance Bio-Pharmaceutical | 904.50M |
| NatureWise Biotech & Medicals | 834.71M |
| BioLASCO Taiwan | 760.68M |
| MegaPro Biomedical | 734.58M |
| SynCore Biotechnology Co.,Ltd | 692.74M |